Understanding the role of mirtrons in human cancers
Official title: Dissecting the role of mirtrons in human cancers
Funded at Texas Tech University · NIH-11064086 · Data updated 2026-11-12
This study is looking at tiny molecules called mirtrons that might play a role in cancer and immune disorders, and it aims to learn how they are made and how they change as cancer develops, which could help create new treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Tech University NIH-funded |
| Lab location | 1 site (Lubbock, United States) |
| Project start | April 1, 2024 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $150,558 |
| NIH project number | 5R16GM153648-02 |
| Project ID | NIH-11064086 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with different types of cancers, particularly those with elevated mirtron levels.
✕Less likely to help
Patients with non-cancerous conditions or those whose cancers do not involve mirtron expression may not benefit from this research.
What this research studies
This research investigates a new class of small RNAs called mirtrons, which have been linked to human cancers and immune disorders. The study aims to understand how mirtrons are produced and how their expression changes during cancer progression. By examining the stability of mirtrons and their interactions with specific enzymes, the research seeks to uncover their biological significance in cancer development. Patients may benefit from insights that could lead to new cancer therapies targeting mirtrons.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating various cancers by targeting mirtron pathways.
How similar studies have gone: While mirtrons are a relatively novel area of study, preliminary findings suggest that similar approaches have shown promise in understanding RNA roles in cancer.
Where this research is happening
-
Texas Tech University
Lubbock, United States Active
Researchers
- Principal investigator: Chen, Kuan-Hui — Texas Tech University
- Study coordinator: Chen, Kuan-Hui
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.